We are not accepting new cases at this time.
In December 2017 Sanofi Genzyme, the manufacturer of Synvisc-One Knee Injections, initiated a voluntary urgent recall of one lot of these injections due to a microbial contamination.
According to a December 19, 2017 press statement released by Sanofi, “the microbe is a common airborne organism and is a rare cause of human infections in both immunocompromised and immunocompetent patients.”
Synvisc-One is a hyaluronic acid gel that is injected into the knee in order to relieve symptoms of arthritis. It works by cushioning and lubricating the joint, and is typically used in patients with arthritis whose pain is not adequately treated with diet, exercise and over-the-counter pain medication.
The identification number for the contaminated lot of Synvisc-One is 7RSL021. Of the 18,000 total syringes in this contaminated lot, 12,380 were distributed across the U.S. between October 25, 2017 and November 7, 2017.
Sanofi warns that infection may result from the contaminated injections, and side effects may include:
- Pain in the knee
- Swelling
- Heat
- Redness
- Fluid build-up in or around the knee
- Difficulty walking
Our law firm is investigating Synvisc-One injections lawsuits on behalf of those who received contaminated injections and experienced the side effects listed above.
Most Recent Article About This Drug
Contamination and Recall of Synvisc-One Knee Injections
Sanofi Genzyme, the manufacturer of Synvisc-One Knee Injections, has initiated a voluntary urgent recall of one lot of the injections due to a microbial contamination.
Synvisc-One is a hyaluronic acid gel that is injected into the knee. It helps treat symptoms of arthritis by cushioning and lubricating the joint, and is typically used in patients with arthritis whose pain is not adequately treated with diet, exercise and over-the-counter pain medication.
To read more of this article, click below: While the side effects experienced by those injected with this contaminated lot of Synvisc-One are similar to the known potential side effects of the injection, there has been an “unexpected increase in the number of labelled adverse events received from the U.S. market,” according to Sanofi spokesperson Heather Guzzi. She did not specify which adverse events were most common among those injected with the contaminated lot, but did state that no deaths had taken place as of December 12, 2017. Sanofi warns that infection may result from contaminated injections, and side effects may include: If you were hospitalized due to any of these symptoms after receiving a Synvisc-One knee injection, we encourage you to complete a Free Case Evaluation. We will continue to monitor the medical and legal news concerning Synvisc-One injections, and report on any significant developments as we become aware of them.
Side Effects